Skip to main content
    C

    Chemours Co (CC)

    Official site

    BASIC MATERIALS • SPECIALTY CHEMICALS • NYSE

    $12.48
    -0.81 (-6.06%)

    Market Cap: $2.00B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Chemours Co (CC) Earnings: Report Dates and Results

    Updated Nov 2, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Chemours (CC) is expected to report earnings on Feb 17, 2027. In the quarter ended Sep 30, 2026, Chemours reported EPS of $0.21, below the $0.26 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    68%(27/40)
    Avg Surprise
    -3.92%

    Upcoming Estimates

    Reports Feb 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.14
    Range$0.08 - $0.20
    14 analysts
    Revenue Consensus
    $1.46B
    Range$1.37B - $1.52B
    12 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.27
    Range$0.23 - $0.34
    5 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.41-32.8%
    60d ago$0.33-17.8%
    30d ago$0.31-11.5%
    7d ago$0.32-13.6%
    Current$0.27
    Revenue Consensus
    $1.43B
    Range$1.41B - $1.44B
    2 analysts

    Next Report

    CC has an expected report date of Feb 17, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 180.0% above the $0.05 reported for the quarter ended Dec 31, 2025.

    CC Earnings Call

    The latest CC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CC beat 27 and missed 13. Revenue for the quarter ended Sep 30, 2026 was $1.54B, up 2.7% from $1.50B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.21$0.26$0.17 - $0.39-19.23%Miss+5.0%90 up, 3 downNov 2, 2026$1.54B
    Jun 30, 2026$0.42$0.43-$0.19 - $0.56-2.33%Miss-27.6%93 up, 0 downAug 4, 2026$1.59B
    Mar 31, 2026$0.05$0.20N/A-75.44%Miss-61.5%83 up, 0 downMay 5, 2026$1.38B
    Dec 31, 2025$0.05$0.02-$0.06 - $0.15+150.00%Beat-54.5%81 up, 1 downFeb 19, 2026$1.33B
    Sep 30, 2025$0.20$0.24$0.20 - $0.29-16.67%Miss-50.0%92 up, 1 downNov 6, 2025$1.50B
    Jun 30, 2025$0.58$0.46$0.38 - $0.53+26.09%Beat+52.6%90 up, 6 downAug 5, 2025$1.61B
    Mar 31, 2025$0.13$0.20$0.14 - $0.36-35.00%Miss-59.4%91 up, 5 downMay 6, 2025$1.37B
    Dec 31, 2024$0.11$0.16$0.04 - $0.40-31.25%Miss-64.5%100 up, 3 downFeb 18, 2025$1.36B
    Sep 30, 2024$0.40$0.28$0.23 - $0.34+42.86%Beat-36.5%90 up, 0 downNov 4, 2024$1.51B
    Jun 30, 2024$0.38$0.58$0.34 - $1.10-34.48%Miss-65.5%90 up, 0 downAug 1, 2024$1.55B
    Mar 31, 2024$0.32$0.17$0.09 - $0.39+88.24%Beat-67.3%70 up, 0 downApr 30, 2024$1.36B
    Dec 31, 2023$0.31$0.25$0.12 - $0.43+24.00%BeatN/A91 up, 0 downMar 27, 2024$1.41B
    Sep 30, 2023$0.63$0.69$0.48 - $0.87-8.70%Miss-49.2%90 up, 0 downOct 26, 2023$1.49B
    Jun 30, 2023$1.10$1.07$1.00 - $1.21+2.80%Beat-41.8%110 up, 0 downJul 27, 2023$1.64B
    Mar 31, 2023$0.98$0.51$0.37 - $0.56+92.16%Beat-32.9%110 up, 1 downApr 27, 2023$1.54B
    Dec 31, 2022-$0.65$0.10-$0.10 - $0.45-746.50%Miss-179.8%110 up, 0 downFeb 9, 2023$1.38B
    Sep 30, 2022$1.24$1.04$0.89 - $1.42+19.23%Beat-2.4%110 up, 0 downOct 25, 2022$1.78B
    Jun 30, 2022$1.89$1.42$1.34 - $1.55+33.10%Beat+57.5%111 up, 0 downJul 28, 2022$1.92B
    Mar 31, 2022$1.46$0.91$0.83 - $1.04+60.44%Beat+105.6%93 up, 0 downMay 2, 2022$1.76B
    Dec 31, 2021$0.81$0.88$0.77 - $0.99-7.95%Miss+30.6%111 up, 0 downFeb 10, 2022$1.57B
    Sep 30, 2021$1.27$1.02$0.95 - $1.08+24.51%Beat+170.2%11N/ANov 4, 2021$1.68B
    Jun 30, 2021$1.20$0.94$0.66 - $1.08+27.66%Beat+566.7%11N/AJul 29, 2021$1.66B
    Mar 31, 2021$0.71$0.64$0.49 - $0.78+10.94%Beat0.0%9N/AMay 3, 2021$1.44B
    Dec 31, 2020$0.62$0.41$0.24 - $0.53+51.22%Beat+10.7%9N/AFeb 11, 2021$1.34B
    Sep 30, 2020$0.47$0.33$0.30 - $0.35+42.42%Beat-20.3%9N/ANov 3, 2020$1.23B
    Jun 30, 2020$0.18$0.11-$0.04 - $0.21+63.64%Beat-75.0%11N/AJul 30, 2020$1.09B
    Mar 31, 2020$0.71$0.49$0.37 - $0.60+44.90%Beat+12.7%11N/AMay 5, 2020$1.30B
    Dec 31, 2019$0.56$0.45$0.36 - $0.49+24.44%Beat-46.7%11N/AFeb 13, 2020$1.35B
    Sep 30, 2019$0.59$0.57$0.51 - $0.71+3.51%Beat-60.4%11N/ANov 4, 2019$1.39B
    Jun 30, 2019$0.72$0.90$0.67 - $1.04-20.00%Miss-57.9%12N/AAug 1, 2019$1.41B
    Mar 31, 2019$0.63$0.94$0.72 - $1.06-32.98%Miss-55.3%11N/AMay 2, 2019$1.38B
    Dec 31, 2018$1.05$1.03$0.90 - $1.13+1.94%Beat-11.8%12N/AFeb 14, 2019$1.46B
    Sep 30, 2018$1.49$1.42$1.32 - $1.56+4.93%Beat+33.0%12N/ANov 1, 2018$1.63B
    Jun 30, 2018$1.71$1.57$1.46 - $1.77+8.92%Beat+96.6%12N/AAug 2, 2018$1.82B
    Mar 31, 2018$1.41$1.22$1.15 - $1.30+15.57%Beat+88.0%9N/AMay 3, 2018$1.73B
    Dec 31, 2017$1.19$0.97$0.82 - $1.10+22.68%Beat+1387.5%8N/AFeb 14, 2018$1.57B
    Sep 30, 2017$1.12$1.04$0.97 - $1.11+7.69%Beat+83.6%7N/ANov 2, 2017$1.58B
    Jun 30, 2017$0.87$0.85$0.78 - $0.94+2.35%Beat+222.2%7N/AAug 2, 2017$1.59B
    Mar 31, 2017$0.75$0.50N/A+50.00%Beat+1150.0%N/AN/AMay 1, 2017$1.44B
    Dec 31, 2016$0.08$0.29N/A-72.41%Miss-50.0%N/AN/AFeb 15, 2017$1.32B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.96, down 20.7% from the year before. It was $1.02 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.96-20.7%
    Dec 31, 2024$1.21-59.9%
    Dec 31, 2023$3.02-23.4%
    Dec 31, 2022$3.94-1.2%
    Dec 31, 2021$3.99+101.5%
    Dec 31, 2020$1.98-20.8%
    Dec 31, 2019$2.50-55.8%
    Dec 31, 2018$5.66+44.0%
    Dec 31, 2017$3.93+285.3%
    Dec 31, 2016$1.02N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,900 words across 12 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,87412
    2026Q2Jun 30, 20266,25313
    2026Q1Mar 31, 20266,21413
    2025Q4Dec 31, 20255,55512
    2025Q3Sep 30, 20256,82516
    2025Q2Jun 30, 20256,52214
    2025Q1Mar 31, 20258,57014
    2024Q4Dec 31, 20247,78210

    2026Q3 Earnings Call

    Opening remarks

    Brandon Ontjes Vice President, Head of Strategy and Investor Relations Good morning, everybody. Welcome to The Chemours Company's Third Quarter 26 Earnings Conference Call. I am joined today by Denise Dignam, Chemours' President and Chief Executive Officer, and our Senior Vice President and Chief Financial Officer, Shane W. Hostetter. Before we start, I would like to remind you that comments made on this call, as well as in the supplemental information provided on our website, contain forward-looking statements and involve risks and uncertainties as described in Chemours' SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events that may not be realized. Actual results may differ, and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information. During this call, we will refer to certain non-GAAP financial measures that we believe are useful to investors evaluating the company's performance. A reconciliation of non-GAAP terms and adjustments is included in our press release issued yesterday evening. Additionally, we also posted our earnings presentation on our website yesterday evening. With that, I will turn the call over to Denise Dignam.

    Denise Dignam President and Chief Executive Officer Thank you, Brandon, and thank you, everyone, for joining us this morning. On today's call, I will start with highlights from our third-quarter performance before turning it over to Shane to walk through our fourth-quarter outlook and initial perspective on 2027. I will then close with an update on our strategic execution under Pathway to Thrive. Our third-quarter results reflected strong year-over-year performance in Titanium Technologies and Advanced Performance Materials, paired with disciplined commercial and operational execution across the company despite weakening macroeconomic conditions across our key end markets. Net sales were up 3% year over year as expected, driven by continued pricing momentum in TT and growth of 26% in the APM Performance Solutions business. These more than offset the anticipated softness in TSS due to expected weaker demand in the North American stationary AC aftermarket for Opteon blends. Adjusted EBITDA was $200 million, at the high end of our guidance range, with all businesses contributing above expectations. With this update, I also want to highlight the progress that we have made under Pathway to Thrive to derisk our balance sheet, continue our efforts to reduce litigation exposure, and address leverage. On the litigation front, we were able to reach a settlement with the state of North Carolina and 11 local entities to resolve claims of PFAS and other discharges from our Fayetteville work site, as well as those unrelated to our site. In addition, we received final approval of the judicial consent order with the state of New Jersey.

    Frequently Asked Questions About CC

    When is Chemours's next earnings date?

    Chemours's next earnings report is expected for Feb 17, 2027.

    Did CC beat earnings estimates last quarter?

    No. Chemours reported EPS of $0.21 for the quarter ended Sep 30, 2026, below the $0.26 estimate by 19.23%.

    What EPS do analysts expect from CC next quarter?

    The consensus EPS estimate for Chemours for the quarter ending Dec 31, 2026 is $0.14 from 14 analysts, with estimates from $0.08 to $0.20.

    How often does CC beat earnings estimates?

    Chemours beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -0.48%.